Cargando…
Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
In recent years, advances in knowledge of molecular mechanisms involved in asthma have changed uncontrolled severe asthma (USA) treatment, with the appearance of biological treatment. USA is a heterogeneous entity with different endotypes and phenotypes. Nowadays, the biological drugs approved with...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701749/ https://www.ncbi.nlm.nih.gov/pubmed/36452259 http://dx.doi.org/10.3389/falgy.2022.1007593 |